Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Hengan International Group Company Limited (1044.HK)
Jinjiang, CN
Hengan International Group Company Limited functions as an investment holding company, with its primary focus on the manufacturing, distribution, and sale of personal care and hygiene products. Its market reach extends across the People's Republic of China and into international territories. The company's extensive product portfolio encompasses a wide array of goods, including various tissue-based items such as pocket handkerchiefs, facial tissues, kitchen paper, and toilet rolls. It also provides feminine hygiene solutions like sanitary napkins, pantiliners, and overnight pants, alongside diapers for both infants and adults, and essential maternal and child care products. Further offerings include wet wipes, first-aid supplies, and a diverse range of household consumables like garbage bags, food storage bags, preservation wrappers, table coverings, and cleaning implements. Beyond its core manufacturing activities, Hengan also engages in the trading of specialized products designed for women, expectant mothers, infants, and children, as well as disposable fiber-based goods. The company maintains a significant presence in the e-commerce sector. Furthermore, the group has diversified its operations to include the generation and supply of heat and power, and the distribution and sale of gas. Its manufacturing capabilities also extend to protective equipment, medical instruments, skincare solutions, antiseptic products, and various other household items. Hengan International Group was established in 1985 and its corporate headquarters are situated in Jinjiang, within the People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.41% | -1.85% | -8.77% | -16.59% | -13.26% | -12.76% | +14.54% | -29.24% | -53.24% | -64.26% | +1,070.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 7 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+1.8% Q4'25: -2.6% (vs Q4'23)
-
EPS growth Household & Personal Products: +8.8%+10.4% ★ Q4'25: -25.0% (vs Q4'23)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+9.0% Q4'25: +10.5% (vs Q4'23)
-
EBIT margin Household & Personal Products: +9.9%+12.7% ★ Q4'25: +10.5% (vs Q4'23)
-
ROIC Household & Personal Products: +8.2%+10.5% ★ Q4'25: +16.5% (vs Q4'23)
-
Share dilution Household & Personal Products: +0.2%-0.2% Q4'25: -1.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×4.04× Q4'25: 2.39× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 8 EPS Ana. |
Dec 2027 9 Rev. Ana. 7 EPS Ana. |
Dec 2028 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.54B
est: 9.58B (-0.4%)
|
11.45B
est: 11.60B (-1.3%)
|
13.80B
est: 14.19B (-2.8%)
|
14.92B
est: 15.90B (-6.2%)
|
16.54B
est: 17.54B (-5.7%)
|
19.06B
est: 19.79B (-3.7%)
|
18.66B
est: 24.66B (-24.3%)
|
19.28B
est: 22.26B (-13.4%)
|
18.08B
est: 23.88B (-24.3%)
|
20.51B
est: 24.01B (-14.6%)
|
22.49B
est: 24.53B (-8.3%)
|
22.37B
est: 27.27B (-17.9%)
|
20.79B
est: 25.81B (-19.4%)
|
22.62B
est: 25.99B (-13.0%)
|
23.77B
est: 21.77B (+9.2%)
|
22.67B
est: 22.75B (-0.3%)
|
23.07B
est: 22.99B (+0.3%)
|
24.54B
23.87B – 25.01B
+6.7% YoY
|
25.23B
24.37B – 25.89B
+2.8% YoY
|
25.98B
25.18B – 26.57B
+3.0% YoY
|
| EBITDA |
2.63B
est: 2.18B (+20.4%)
|
2.96B
est: 3.04B (-2.6%)
|
3.10B
est: 3.66B (-15.2%)
|
4.27B
est: 3.35B (+27.5%)
|
4.73B
est: 4.38B (+8.1%)
|
5.27B
est: 5.01B (+5.1%)
|
5.38B
est: 5.37B (+0.3%)
|
5.38B
est: 4.68B (+14.9%)
|
5.33B
est: 5.11B (+4.4%)
|
5.60B
est: 5.63B (-0.5%)
|
5.78B
est: 5.29B (+9.4%)
|
6.02B
est: 5.86B (+2.8%)
|
4.55B
est: 6.29B (-27.7%)
|
4.12B
est: 6.87B (-39.9%)
|
5.14B
est: 4.28B (+20.2%)
|
4.43B
est: 7.94B (-44.2%)
|
3.90B
est: 4.52B (-13.6%)
|
4.82B
4.69B – 4.91B
+6.7% YoY
|
4.96B
4.79B – 5.09B
+2.8% YoY
|
5.10B
4.95B – 5.22B
+3.0% YoY
|
| EBIT |
2.32B
est: 1.89B (+23.0%)
|
2.64B
est: 2.78B (-4.8%)
|
2.74B
est: 3.23B (-15.2%)
|
3.82B
est: 3.06B (+24.8%)
|
4.18B
est: 4.25B (-1.6%)
|
4.67B
est: 4.56B (+2.3%)
|
4.81B
est: 5.49B (-12.4%)
|
4.75B
est: 4.76B (-0.2%)
|
4.66B
est: 4.72B (-1.2%)
|
4.87B
est: 5.57B (-12.6%)
|
4.97B
est: 5.59B (-11.1%)
|
5.24B
est: 6.36B (-17.6%)
|
3.74B
est: 6.83B (-45.1%)
|
3.31B
est: 7.45B (-55.5%)
|
4.24B
est: 3.41B (+24.2%)
|
3.45B
est: 3.61B (-4.4%)
|
2.93B
est: 3.61B (-18.6%)
|
3.85B
3.74B – 3.92B
+6.7% YoY
|
3.96B
3.82B – 4.06B
+2.8% YoY
|
4.07B
3.95B – 4.17B
+3.0% YoY
|
| Net Income |
1.86B
est: 1.66B (+12.6%)
|
2.08B
est: 2.26B (-8.1%)
|
2.14B
est: 2.63B (-18.4%)
|
2.83B
est: 2.46B (+15.0%)
|
2.91B
est: 3.16B (-7.9%)
|
3.13B
est: 3.34B (-6.1%)
|
3.39B
est: 3.74B (-9.2%)
|
3.60B
est: 3.17B (+13.3%)
|
3.79B
est: 3.58B (+6.1%)
|
3.80B
est: 4.01B (-5.3%)
|
3.91B
est: 3.91B (-0.2%)
|
4.59B
est: 4.37B (+5.1%)
|
3.27B
est: 4.70B (-30.3%)
|
1.93B
est: 1.87B (+2.7%)
|
2.80B
est: 2.78B (+0.9%)
|
2.30B
est: 2.48B (-7.3%)
|
2.54B
est: 2.28B (+11.3%)
|
2.66B
2.39B – 2.93B
+17.0% YoY
|
2.81B
2.56B – 3.06B
+5.4% YoY
|
2.80B
2.50B – 3.10B
-0.3% YoY
|
| SGA |
2.19B
est: 2.18B (+0.5%)
|
2.72B
est: 2.65B (+2.5%)
|
3.21B
est: 3.44B (-6.8%)
|
3.33B
est: 3.68B (-9.6%)
|
4.10B
est: 3.71B (+10.3%)
|
5.12B
est: 4.56B (+12.2%)
|
4.60B
est: 5.91B (-22.2%)
|
5.20B
est: 4.32B (+20.6%)
|
3.42B
est: 4.97B (-31.2%)
|
3.47B
est: 3.44B (+0.9%)
|
4.49B
est: 3.37B (+33.6%)
|
4.84B
est: 5.03B (-3.9%)
|
4.54B
est: 5.40B (-16.0%)
|
4.91B
est: 5.90B (-16.8%)
|
5.07B
est: 4.82B (+5.2%)
|
5.11B
est: 6.82B (-25.1%)
|
5.36B
est: 5.09B (+5.4%)
|
5.43B
5.28B – 5.53B
+6.7% YoY
|
5.58B
5.39B – 5.73B
+2.8% YoY
|
5.75B
5.57B – 5.88B
+3.0% YoY
|
| EPS |
1.56
est: 1.33 (+17.6%)
|
1.70
est: 1.47 (+15.9%)
|
1.75
est: 1.44 (+21.7%)
|
2.31
est: 1.89 (+22.0%)
|
2.36
est: 2.03 (+16.2%)
|
2.55
est: 1.99 (+28.1%)
|
2.62
est: 3.31 (-20.9%)
|
2.73
est: 3.26 (-16.3%)
|
3.15
est: 3.66 (-13.8%)
|
3.15
est: 3.61 (-12.9%)
|
3.28
est: 3.62 (-9.5%)
|
3.86
est: 4.64 (-16.8%)
|
2.79
est: 3.44 (-18.8%)
|
1.66
est: 2.33 (-28.8%)
|
2.41
est: 2.41 (-0.2%)
|
2.01
est: 2.19 (-8.2%)
|
2.23
est: 2.01 (+11.0%)
|
2.32
2.10 – 2.58
+15.4% YoY
|
2.39
2.25 – 2.69
+2.9% YoY
|
2.45
2.20 – 2.72
+2.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-14 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ching Lau Hui | Chief Executive Officer & Executive Director | 17M | male |
| Ching Chi Hui | Group Vice President & Executive Director | 3M | male |
| Wai Leung Li FCPA | Chief Financial Officer, Company Secretary & Executive Director | 2M | male |
| Da Zuo Xu | Vice President & Executive Director | 2M | male |
| Wen Mo Xu | Vice President & Executive Director | 2M | male |
| Man Bok Sze | Executive Chairman of the Board | 493.0K | male |
| Wong Kim Sze | Executive Director | 67.0K | male |
| Yue Jin Ruan | General Manager of Internal Audit Department | — | male |
| Jian Shui Zhu | Financial Controller of Mainland China | — | male |
| Li Li | Director of Marketing Department | — | female |
| Ying Liu | Director of Administration Department | — | female |
| Yiu Chi Pang | Finance & Investor Relations Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1044.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
